"[\n    {\n        \"id\": \"molgod-e7ce54dce388df18b626ed6d383a8c35\",\n        \"type\": \"article-journal\",\n        \"title\": \"Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism.\",\n        \"author\": [\n            {\n                \"family\": \"al.\",\n                \"given\": \"et\"\n            }\n        ],\n        \"container-title\": \"\",\n        \"issued\": {\n            \"date-parts\": [\n                [\n                    2019\n                ]\n            ]\n        },\n        \"DOI\": \"10.1126\\\/science.aau6323\",\n        \"PMID\": \"31196984\",\n        \"URL\": \"https:\\\/\\\/europepmc.org\\\/articles\\\/PMC7745125?pdf=render\"\n    },\n    {\n        \"id\": \"molgod-24e6a467e180fc3b92877efa504f7748\",\n        \"type\": \"article-journal\",\n        \"title\": \"Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease.\",\n        \"author\": [\n            {\n                \"family\": \"al.\",\n                \"given\": \"et\"\n            }\n        ],\n        \"container-title\": \"\",\n        \"issued\": {\n            \"date-parts\": [\n                [\n                    2019\n                ]\n            ]\n        },\n        \"DOI\": \"10.1038\\\/s41467-019-08294-y\",\n        \"PMID\": \"30659181\",\n        \"URL\": \"https:\\\/\\\/www.nature.com\\\/articles\\\/s41467-019-08294-y.pdf\"\n    },\n    {\n        \"id\": \"molgod-3dc4bfe5506be283dfed4d9b1920b0f3\",\n        \"type\": \"article-journal\",\n        \"title\": \"Levodopa Is a Double-Edged Sword for Balance and Gait in People With Parkinson's Disease.\",\n        \"author\": [\n            {\n                \"family\": \"al.\",\n                \"given\": \"et\"\n            }\n        ],\n        \"container-title\": \"\",\n        \"issued\": {\n            \"date-parts\": [\n                [\n                    2015\n                ]\n            ]\n        },\n        \"DOI\": \"10.1002\\\/mds.26269\",\n        \"PMID\": \"26095928\",\n        \"URL\": \"https:\\\/\\\/www.ncbi.nlm.nih.gov\\\/pmc\\\/articles\\\/4755510\"\n    },\n    {\n        \"id\": \"molgod-b4b8a483fdce80621dfb52561945b309\",\n        \"type\": \"article-journal\",\n        \"title\": \"The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa.\",\n        \"author\": [\n            {\n                \"family\": \"al.\",\n                \"given\": \"et\"\n            }\n        ],\n        \"container-title\": \"\",\n        \"issued\": {\n            \"date-parts\": [\n                [\n                    2014\n                ]\n            ]\n        },\n        \"DOI\": \"10.1093\\\/brain\\\/awu195\",\n        \"PMID\": \"25034897\",\n        \"URL\": \"https:\\\/\\\/europepmc.org\\\/articles\\\/PMC4163032?pdf=render\"\n    },\n    {\n        \"id\": \"molgod-e05f1939ee3cbcd7dcf5290e6cf6bd1e\",\n        \"type\": \"article-journal\",\n        \"title\": \"Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.\",\n        \"author\": [\n            {\n                \"family\": \"al.\",\n                \"given\": \"et\"\n            }\n        ],\n        \"container-title\": \"\",\n        \"issued\": {\n            \"date-parts\": [\n                [\n                    2014\n                ]\n            ]\n        },\n        \"DOI\": \"10.1016\\\/s1474-4422(13)70293-x\",\n        \"PMID\": \"24361112\"\n    },\n    {\n        \"id\": \"molgod-86d5701e0f1a6dfe2396815dab0403ca\",\n        \"type\": \"article-journal\",\n        \"title\": \"Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease.\",\n        \"author\": [\n            {\n                \"family\": \"al.\",\n                \"given\": \"et\"\n            }\n        ],\n        \"container-title\": \"\",\n        \"issued\": {\n            \"date-parts\": [\n                [\n                    2013\n                ]\n            ]\n        },\n        \"DOI\": \"10.1002\\\/mds.25364\",\n        \"PMID\": \"23630119\"\n    },\n    {\n        \"id\": \"molgod-8d24b3c1994b486b67401ef65db40b0a\",\n        \"type\": \"article-journal\",\n        \"title\": \"Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial.\",\n        \"author\": [\n            {\n                \"family\": \"al.\",\n                \"given\": \"et\"\n            }\n        ],\n        \"container-title\": \"\",\n        \"issued\": {\n            \"date-parts\": [\n                [\n                    2014\n                ]\n            ]\n        },\n        \"DOI\": \"10.1016\\\/s0140-6736(14)60683-8\",\n        \"PMID\": \"24928805\"\n    },\n    {\n        \"id\": \"molgod-4dd2170dab1f2604d455f001dad768e1\",\n        \"type\": \"article-journal\",\n        \"title\": \"Levodopa and the progression of Parkinson's disease.\",\n        \"author\": [\n            {\n                \"family\": \"al.\",\n                \"given\": \"et\"\n            }\n        ],\n        \"container-title\": \"\",\n        \"issued\": {\n            \"date-parts\": [\n                [\n                    2004\n                ]\n            ]\n        },\n        \"DOI\": \"10.1056\\\/nejmoa033447\",\n        \"PMID\": \"15590952\",\n        \"URL\": \"https:\\\/\\\/www.nejm.org\\\/doi\\\/pdf\\\/10.1056\\\/NEJMoa033447?articleTools=true\"\n    },\n    {\n        \"id\": \"molgod-d5e14015769f624247ce40cce0be5681\",\n        \"type\": \"article-journal\",\n        \"title\": \"A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.\",\n        \"author\": [\n            {\n                \"family\": \"al.\",\n                \"given\": \"et\"\n            }\n        ],\n        \"container-title\": \"\",\n        \"issued\": {\n            \"date-parts\": [\n                [\n                    2000\n                ]\n            ]\n        },\n        \"DOI\": \"10.1056\\\/nejm200005183422004\",\n        \"PMID\": \"10816186\",\n        \"URL\": \"https:\\\/\\\/www.nejm.org\\\/doi\\\/pdf\\\/10.1056\\\/NEJM200005183422004?articleTools=true\"\n    },\n    {\n        \"id\": \"molgod-6a485bbc5f4c4c369ec4f5b6ef62245e\",\n        \"type\": \"article-journal\",\n        \"title\": \"Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial.\",\n        \"author\": [\n            {\n                \"family\": \"al.\",\n                \"given\": \"et\"\n            }\n        ],\n        \"container-title\": \"\",\n        \"issued\": {\n            \"date-parts\": [\n                [\n                    2005\n                ]\n            ]\n        },\n        \"DOI\": \"10.1016\\\/s0140-6736(05)71083-7\",\n        \"PMID\": \"15766996\",\n        \"URL\": \"http:\\\/\\\/hdl.handle.net\\\/10400.16\\\/429\"\n    },\n    {\n        \"id\": \"molgod-6f649f117c358fb85c6800976ffefc3b\",\n        \"type\": \"article-journal\",\n        \"title\": \"Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias.\",\n        \"author\": [\n            {\n                \"family\": \"al.\",\n                \"given\": \"et\"\n            }\n        ],\n        \"container-title\": \"\",\n        \"issued\": {\n            \"date-parts\": [\n                [\n                    2004\n                ]\n            ]\n        },\n        \"DOI\": \"10.1093\\\/brain\\\/awh290\",\n        \"PMID\": \"15329355\",\n        \"URL\": \"https:\\\/\\\/academic.oup.com\\\/brain\\\/article-pdf\\\/127\\\/12\\\/2747\\\/959090\\\/awh290.pdf\"\n    },\n    {\n        \"id\": \"molgod-e59a232945ad6c69170296cb417098e4\",\n        \"type\": \"article-journal\",\n        \"title\": \"Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa.\",\n        \"author\": [\n            {\n                \"family\": \"al.\",\n                \"given\": \"et\"\n            }\n        ],\n        \"container-title\": \"\",\n        \"issued\": {\n            \"date-parts\": [\n                [\n                    1997\n                ]\n            ]\n        },\n        \"DOI\": \"10.1073\\\/pnas.94.7.3363\",\n        \"PMID\": \"9096399\",\n        \"URL\": \"https:\\\/\\\/www.ncbi.nlm.nih.gov\\\/pmc\\\/articles\\\/20375\"\n    },\n    {\n        \"id\": \"molgod-7e5a957b9cc6241af2aecd30d316477b\",\n        \"type\": \"article-journal\",\n        \"title\": \"Effects of deep brain stimulation and levodopa on postural sway in Parkinson's disease.\",\n        \"author\": [],\n        \"container-title\": \"\",\n        \"issued\": {\n            \"date-parts\": [\n                [\n                    2002\n                ]\n            ]\n        },\n        \"DOI\": \"10.1136\\\/jnnp.73.3.267\",\n        \"PMID\": \"12185157\",\n        \"URL\": \"https:\\\/\\\/jnnp.bmj.com\\\/content\\\/jnnp\\\/73\\\/3\\\/267.full.pdf\"\n    },\n    {\n        \"id\": \"molgod-21c047db64eda73a39751633ec4c4d76\",\n        \"type\": \"article-journal\",\n        \"title\": \"Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature.\",\n        \"author\": [],\n        \"container-title\": \"\",\n        \"issued\": {\n            \"date-parts\": [\n                [\n                    2001\n                ]\n            ]\n        },\n        \"DOI\": \"10.1002\\\/mds.1090\",\n        \"PMID\": \"11391738\"\n    },\n    {\n        \"id\": \"molgod-212d3eff49393ace1f5223a2a655c70e\",\n        \"type\": \"article-journal\",\n        \"title\": \"Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.\",\n        \"author\": [\n            {\n                \"family\": \"al.\",\n                \"given\": \"et\"\n            }\n        ],\n        \"container-title\": \"\",\n        \"issued\": {\n            \"date-parts\": [\n                [\n                    2003\n                ]\n            ]\n        },\n        \"DOI\": \"10.1002\\\/ana.10609\",\n        \"PMID\": \"12838524\"\n    },\n    {\n        \"id\": \"molgod-d057c8135b46899840949392a9e90858\",\n        \"type\": \"article-journal\",\n        \"title\": \"Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.\",\n        \"author\": [],\n        \"container-title\": \"\",\n        \"issued\": {\n            \"date-parts\": [\n                [\n                    2002\n                ]\n            ]\n        },\n        \"DOI\": \"10.1001\\\/jama.287.13.1653\",\n        \"PMID\": \"11926889\"\n    },\n    {\n        \"id\": \"molgod-10958a5e1ecddeb134a16d267b3b6fb1\",\n        \"type\": \"article-journal\",\n        \"title\": \"Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson's disease.\",\n        \"author\": [\n            {\n                \"family\": \"al.\",\n                \"given\": \"et\"\n            }\n        ],\n        \"container-title\": \"\",\n        \"issued\": {\n            \"date-parts\": [\n                [\n                    2003\n                ]\n            ]\n        },\n        \"DOI\": \"10.1046\\\/j.1468-1331.2003.00611.x\",\n        \"PMID\": \"12823491\"\n    },\n    {\n        \"id\": \"molgod-c0bdb051917f1a3534fee71391102e92\",\n        \"type\": \"article-journal\",\n        \"title\": \"Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia.\",\n        \"author\": [\n            {\n                \"family\": \"al.\",\n                \"given\": \"et\"\n            }\n        ],\n        \"container-title\": \"\",\n        \"issued\": {\n            \"date-parts\": [\n                [\n                    2005\n                ]\n            ]\n        },\n        \"DOI\": \"10.1002\\\/ana.20296\",\n        \"PMID\": \"15514976\"\n    },\n    {\n        \"id\": \"molgod-9d529768030a122c5e0ac618b9073c41\",\n        \"type\": \"article-journal\",\n        \"title\": \"Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.\",\n        \"author\": [\n            {\n                \"family\": \"al.\",\n                \"given\": \"et\"\n            }\n        ],\n        \"container-title\": \"\",\n        \"issued\": {\n            \"date-parts\": [\n                [\n                    2005\n                ]\n            ]\n        },\n        \"DOI\": \"10.1002\\\/mds.20629\",\n        \"PMID\": \"16078219\"\n    },\n    {\n        \"id\": \"molgod-429aac5df129ca187c12aca37f10651a\",\n        \"type\": \"article-journal\",\n        \"title\": \"The effect of deprenyl and levodopa on the progression of Parkinson's disease.\",\n        \"author\": [\n            {\n                \"family\": \"al.\",\n                \"given\": \"et\"\n            }\n        ],\n        \"container-title\": \"\",\n        \"issued\": {\n            \"date-parts\": [\n                [\n                    1995\n                ]\n            ]\n        },\n        \"DOI\": \"10.1002\\\/ana.410380512\",\n        \"PMID\": \"7486869\"\n    }\n]"